RE:RE:RE:Rockin Rory RiggsGeez, "Mr Riggs is ... GeneNews". Really, could not even get the company name right. It's StageZero now yall. A old nr that was heated up in the microwave. Basically means another q3 and fins with SFA for the shareholders. Thanks for the heads up. Oh yeah if you happen to be in contact with that mutt nailbiter1/2 tell it to go phuque itself or are you all the same lame excuse for a human being with multiple personalities and handles on stockhouse. Biggest pump and dump I have ever had the displeasure to be involved with. Oh well, my oil and gas stocks will more than cover this loser. Phuque Joe Biden.
LithLover wrote: Maybe check the filings today. Likely explains how funding for operations continues and why a man of his wealth and connections continues to support Stage. Wake up
IainCaimbeul wrote: Are you really that stunned to be pumping him when the stock is pre rs value? Wake up.
LithLover wrote: Mr. Riggs is co-founder and Chairman of Royalty Pharma, the largest acquirer of drug royalties, and Cibus Global Ltd., the leading company in gene editing in agriculture. In addition, he sits on the following other boards of directors: Intra-Cellular Therapies, Inc., Nuredis, Inc., GeneNews, Ltd. and eReceivables, LLC (Chair). Since June 2006, Mr. Riggs has also served as managing member of New Ventures, a series of venture funds focused on biotechnology and healthcare. Mr. Riggs served as the President of Biomatrix, Inc., a biomedical company, from 1996 until 2000. From 1991 to 1995, he was Chief Executive Officer of RF&P Corporation, an investment company owned by the Virginia Retirement System. He was also Managing Director of PaineWebber and Company, in the mergers and acquisitions department. Mr. Riggs holds a Bachelor of Arts degree from Middlebury College, Vermont and a Master of Business Administration degree from Columbia University